|
17 Sep 2025 |
Colgate-Palmolive
|
Consensus Share Price Target
|
2355.80 |
2522.65 |
- |
7.08 |
hold
|
|
|
|
|
02 Feb 2017
|
Colgate-Palmolive
|
Axis Direct
|
2355.80
|
840.00
|
906.00
(160.02%)
|
|
Hold
|
|
|
Net sales, EBITDA and adj. PAT declined 9%/10%/14%. With mid-single digit price hike, volume declined 12% in Q3FY17. Toothpaste and toothbrush market share stood at 54.5% (down 190bps YoY) and 48.2% (up 290 bps YoY). Higher other operating expenses (+219 bps YoY at 22.6%) and employee costs (+60 bps..
|
|
30 Jan 2017
|
Colgate-Palmolive
|
ICICI Securities Limited
|
2355.80
|
950.00
|
884.25
(166.42%)
|
Target met |
Hold
|
|
|
ICICI Securities Ltd | Retail Equity Research Colgate-Palmolive (CPIL) reported a disappointing Q3FY17 performance. Revenue for the quarter declined 8.6% YoY to | 981.6 crore (I-direct estimate: | 947.1 crore) amid demonetisation and increasing competitive intensity. We anticipate ~10-12% decline in volumes considering ~3.0% price decline during the quarter In line with estimates, the company undertook a cut in the advertisement expense in order to mitigate impact of lower sales on...
|
|
28 Jan 2017
|
Colgate-Palmolive
|
HDFC Securities
|
2355.80
|
909.00
|
880.50
(167.55%)
|
Target met |
Neutral
|
|
|
Colgates net revenue was down by 8.8% YoY to Rs 8.7bn, our expectation was 2% fall. Volume contracted by sharp 12% YoY. EBITDA & APAT grew by -10.3% & -22.6% YoY.
|
|
02 Nov 2016
|
Colgate-Palmolive
|
HDFC Securities
|
2355.80
|
943.00
|
959.80
(145.45%)
|
Target met |
Neutral
|
|
|
Colgates net revenue was up by 9.5% YoY to Rs 10.6bn, slightly lower than our expectation of 11% growth. Volume growth remained challenging and stood at 4%. EBITDA & APAT grew by 8% & 16%.
|
|
01 Nov 2016
|
Colgate-Palmolive
|
ICICI Securities Limited
|
2355.80
|
1042.00
|
972.35
(142.28%)
|
Target met |
Hold
|
|
|
ICICI Securities Ltd | Retail Equity Research Colgate-Palmolive (CPIL) reported a healthy performance on both revenue and profit front. However, the margin contracted slightly on a YoY basis. Revenue for the company grew 9.8% YoY to | 1194.9 crore led by 4% volume growth (I-direct estimate: | 1148.9 crore). Domestic volume growth was at 4% in the quarter. The company launched two new products in the toothpaste category, namely, Colgate MaxFresh Power Freeze and Colgate Kids toothpaste...
|
|
01 Nov 2016
|
Colgate-Palmolive
|
Reliance Securities
|
2355.80
|
1105.00
|
972.35
(142.28%)
|
Target met |
Buy
|
|
|
Favourable Risk Reward Ratio Warrants Rating Upgrade Net revenue of Colgate-Palmolive (India) grew by 9.4% yoy to Rs10.5bn, while net profit increased 15.6% yoy to Rs1.8bn in 2QFY17. The Company's overall volume grew by 4% yoy during the quarter. Notably, prior period tax reversal worth Rs142mn...
|
|
09 Aug 2016
|
Colgate-Palmolive
|
Phillip Capital
|
2355.80
|
1110.00
|
971.30
(142.54%)
|
Target met |
Buy
|
|
|
Top takeaways from Q1FY17: Revenue growth at 12.5% yoy was ahead of our/street estimates.Volume growth at 6% yoy with domestic volume growth of 5% yoy was in line; pricing growth continued to be robust at 6% yoy. Market share in Tooth paste recovered 60bps qoq to 55.9%; Tooth brush share improved 100 bps qoq to 46.8%.Gross margins rose 240bps yoy and surprised positively. EBIDTA margins shrunk 160bps yoy on higher ad spends and EBITDA growth missed estimates.Phillip Capital value the company at 40x, FY18E earnings (35x earlier) at Rs 1110 (earlier Rs 960) and maintain Buy.
Trendlyne has 11 reports on COLPAL updated in the last year from 4 brokers with an average target of Rs 995.5. Brokers have a rating for COLPAL with 2 price downgrades,1 price upgrade in past 6 months and 1 upgrade,2 price upgrades in past 1 Year.
|
|
09 Aug 2016
|
Colgate-Palmolive
|
ICICI Securities Limited
|
2355.80
|
971.00
|
971.30
(142.54%)
|
|
Hold
|
|
|
ICICI Securities Ltd | Retail Equity Research Colgate-Palmolive (CPIL) posted healthy topline growth led by strong 6% volume growth. Domestic volume growth was at 5% in the...
|
|
09 Aug 2016
|
Colgate-Palmolive
|
Reliance Securities
|
2355.80
|
1055.00
|
971.30
(142.54%)
|
|
Hold
|
|
|
Net sales of Colgate Palmolive (India) grew 8.9% yoy to Rs10.1bn, while EBITDA growth was recorded at 3.6% and PBT (before exceptional items) increased by just 1.7% to Rs1.9bn in the quarter ended June 30, 2016. It reported overall volume growth of 6% with domestic volume growing by 5%. While gross sales growth was higher at 12.5%, net sales grew just 8.9% on account of sharp 49% jump in tax outgo resulting from phasing out of Excise Duties benefits. Going forward, we estimate the volume growth to pick up pace, especially with the launch of Cibaca Vedshakti in the naturals space at an attractive price point. However,...
|
|
08 Aug 2016
|
Colgate-Palmolive
|
Motilal Oswal
|
2355.80
|
1190.00
|
1016.40
(131.78%)
|
|
Buy
|
|
|
Colgate-Palmolive (CLGT) posted net sales growth of 8.9% YoY (est. of 9.5%) to INR10.1b (Ind-AS). Adjusting for excise impact YoY, organic sales growth was 12.5% YoY, led by 6% volume growth, including exports and 5% domestic volume growth (est. of +4.5%; highest in the past five quarters), selective price increases and product mix changes. EBITDA was up 3.7% YoY (est. of +19.6%) to INR2.11b, mainly because of higher A&P; YoY, while Adj. PAT was up 1.3% YoY (est. of +20.8% YoY) to INR1.26b. Toothpaste market share improved 60bp sequentially to 55.9%, while...
|